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PEMBANGUNAN MODEL KOMPREHENSIF YANG BERASASKAN 
KOMUNITI BAGI MENGURUS PESAKIT DEMENSIA DENGAN BPSD DI 
KAWASAN PEDALAMAN DI THAILAND 
ABSTRAK 
Simptom kelakuan dan psikologi demensia (BPSD) adalah biasa dalam kalangan 
pesakit demensia dan merupakan salah satu daripada sebab-sebab yang 
membebankan pengasuh. Ketiadaan kemudahan penjagaan jangka panjang di luar 
bandar Thailand telah mewujudkan keperluan untuk penglibatan komuniti dalam 
pengurusan pesakit demensia dengan BPSD. Objektif kajian ini ialah: (1) meneroka 
masalah dalam pengurusan pesakit demensia dengan BPSD; (2) membentuk satu 
model komprehensif melalui pemetaan konsep bersepadu; (3) menilai dan 
mengubahsuai model yang telah dibangunkan berdasarkan maklum balas peserta. 
Pendekatan kualitatif iaitu temubual dan kumpulan fokus digunakan untuk 
pengumpulan data dalam tiga fasa. Di samping itu, pemetaan konsep bersepadu telah 
digunakan untuk mereka bentuk model komprehensif dan model berasaskan 
komuniti dengan enam langkah: penyediaan, penjanaan idea, penstrukturan idea, 
pengiraan peta, tafsiran, dan penggunaan. Dalam fasa 1, seramai sebelas pasangan 
pesakit demensia dan pengasuh terlibat dalam kajian. Pengurusan yang tidak sesuai 
telah diterangkan dari segi masalah dalam menguruskan pesakit demensia dengan 
BPSD seperti kurang penekanan pada intervensi bukan farmakologi, kecuaian, 
penahanan, keganasan lisan, dan kurang penglibatan daripada komuniti. Dalam fasa 
2, peserta yang terdiri daripada enam ahli penjagaan kesihatan profesional dan 
sembilan penjaga kesihatan bukan profesional terlibat dalam proses pemetaan konsep 
bersepadu dan menjana sejumlah 48 idea dengan 8 tema mencerminkan kelompok: 
(1) piawai prosedur hospital untuk penjagaan demensia; (2) penjagaan yang cekap, 
mudah dan berterusan; (3) pemantauan dan penilaian yang berterusan; (4) kaedah 
 xvi 
 
untuk berkomunikasi dengan pesakit; (5) panduan untuk penjagaan keluarga; (6) 
sokongan emosi dan perkongsian pengalaman dalam kalangan kumpulan sokongan 
rakan sebaya; (7) pembentukan komuniti mesra demensia mesra dan penyayang; dan 
(8) komunikasi, pemantauan, dan kerjasama. Idea yang paling penting dan yang 
boleh dilaksanakan telah dikumpulkan bersama ke dalam 6 tema untuk mereka 
bentuk satu model yang menyeluruh. Model ini merangkumi prosedur untuk 
pengurusan pesakit demensia dengan BPSD melalui hospital dan penglibatan 
komuniti dan ia telah diaplikasikan selama 2 bulan di mukim A di dalam daerah 
Kuchianarai. Dua aktiviti utama yang baharu telah digunakan dalam amalan sebenar: 
"Pendidikan demensia untuk sukarelawan kesihatan kampung dan pemimpin 
masyarakat" dan "Perkongsian dan pembelajaran dalam kalangan ahli keluarga". 
Selain aktiviti-aktiviti ini, model ini juga telah diintegrasikan ke dalam kerja rutin di 
hospital Crown Prince Kuchinarai. Secara keseluruhan, 19 daripada 26 komponen 
(73.1%) yang diperolehi dari peta konsep adalah sesuai untuk digunakan dalam 
amalan sebenar. Akhir sekali, model berasaskan komuniti digambarkan dalam bentuk 
peta konsep berdasarkan prinsip sistem kesihatan daerah, pengagihan sumber, 
pendekatan berasaskan projek, klinik demensia dengan pembentangan kes oleh 
pasukan inter-disiplin, dan aktiviti-aktiviti dilaksanakan dalam model pertama seperti 
kumpulan sokongan rakan sebaya dan pendidikan komuniti. Kesimpulannya, model 
komprehensif yang berasaskan komuniti bagi mengurus pesakit demensia dengan 
BPSD melibatkan kerjasama di antara ahli profesional penjagaan kesihatan dan 
masyarakat melalui sukarelawan kesihatan kampung. 
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DEVELOPMENT OF THE COMPREHENSIVE COMMUNITY-BASED 
MODEL FOR MANAGING DEMENTIA PATIENTS WITH BPSD IN A 
RURAL AREA IN THAILAND 
ABSTRACT 
Behavioural and psychological symptoms of dementia (BPSD) are common in 
dementia patients and one of the causes that burden caregivers. No long-term care 
facility in rural Thailand creates the needs for the community involvement in 
managing dementia patients with BPSD. The objectives of the study were: (1) 
exploring the problems in managing dementia patients with BPSD; (2) designing a 
comprehensive model through integrated concept mapping; (3) evaluating and 
modifying a developed model based on participants’ feedback. Qualitative 
approaches such as interviews and focus groups were mainly used for data collection 
over three phases. In addition, integrated concept mapping was applied to design a 
comprehensive model and a community-based model with the six steps: preparation, 
idea generation, idea structuring, computing the map, interpretation, and utilisation. 
In phase 1, eleven dyads of dementia patients and caregivers were sampled. 
Inappropriate management was described in terms of problems in managing 
dementia patients with BPSD such as less emphasis on non-pharmacological 
interventions, negligence, detention, verbal violence, and less participation of the 
community. In phase 2, participants consisting of six healthcare professionals and 
nine non-healthcare professionals were involved in the integrated concept mapping 
process and generated a total of 48 ideas with 8 cluster-reflected themes: (1) standard 
hospital procedures for dementia care; (2) efficient, accessible and continual care; (3) 
continuous monitoring and evaluation; (4) methods of communicating with patients; 
(5) guidance for family care; (6) emotional support and experience sharing among 
peer support groups; (7) building a dementia-friendly and caring community; and (8) 
 xviii 
 
communication, monitoring, and cooperation. Highly important and highly feasible 
ideas were incorporated into 6 themes to design a comprehensive model. The model 
consists of procedures for managing dementia patients with BPSD through hospital 
and community involvement and was applied for 2 months in sub-district A of the 
Kuchianarai district. Two main new activities were applied in real practice: 
“Dementia education for village health volunteers and community leaders” and 
“Sharing and learning among relatives”. In addition to these activities, the model was 
integrated into the routine work of Crown Prince Kuchinarai Hospital as well. 
Overall, 19 of the 26 components (73.1%) obtained from concept mapping were 
feasible to apply in real practice. Finally, a community-based model was depicted in 
the form of a concept map based on the district health system principle, resource 
allocation, a project-based approach, dementia clinics with case conferences by 
interdisciplinary teams, and the feasible activities in the first model such as a peer 
support group and community education. In conclusion, a community-based model 
for managing dementia patients with BPSD involves the cooperation between 
healthcare professionals and the community via village health volunteers. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background of the Study 
Dementia is a neurodegenerative disease that is commonly found in older people. In 
2010, the worldwide prevalence of dementia among the elderly was approximately 5-
7% (Prince et al., 2013). In other words, 35.6 million people suffered from dementia 
worldwide. Furthermore, the numbers are projected to increase to 65.7 million in 
2030 and 115.4 million by 2050 (Prince et al., 2013). Moreover, dementia also has an 
impact on healthcare costs worldwide. For instance, Wimo, Jonsson, Bond, Prince, 
and Winblad (2013) estimate global expenditures on dementia care in 2010 as 
roughly US$604 billion.  
Additionally, there is currently no effective, evidence-based method to prevent 
dementia (Carrillo et al., 2013). Anti-dementia agents only help slow the disease’s 
progression but cannot stop or cure it. Therefore, healthcare providers must use 
multiple strategies to manage dementia patients, including both pharmacological and 
non-pharmacological interventions (Ridde & Sombie, 2012). For example, for 
pharmacological interventions, anti-dementia and anti-psychotic agents are used to 
delay the disease’s progression and to control behavioural and psychological 
symptoms of dementia (BPSD). However, non-pharmacological interventions also 
help improve patients’ symptoms: examples include modifying the environment, 
exercise, rehabilitation, behavioural therapy, and cognitive training. Finally, 
palliative care is needed for patients in the severe stage. Therefore, nursing homes 
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are crucial for these patients, especially those in the middle and later stages of 
dementia. 
BPSD, for example, agitation, wandering, aggression, hallucinations, and delusions, 
are common in dementia patients. Often, both dementia patients and caregivers suffer 
from these symptoms (Hurt et al., 2008). Some BPSD, for example, excessive night-
time activity, contribute to institutionalisation (Hope, Keene, Gedling, Fairburn, & 
Jacoby, 1998). Anti-psychotic agents can relieve some symptoms of BPSD. 
However, the use of these medicines is limited because of the increased mortality 
rates caused by antipsychotic use in dementia patients (Musicco et al., 2011). 
Therefore, antipsychotics are recommended for only short-term use in patients with 
severe symptoms (Azermai et al., 2012). Nevertheless, some dementia patients have 
been prescribed antipsychotics inappropriately, resulting in both harm to the patients 
and their increased mortality (Ahmad, Norman, & O'Campo, 2012; Nowicki, Brown, 
& Stepien, 2013). Some studies have shown that trained pharmacists can help correct 
the inappropriate use of antipsychotics using medication reviews (Drachsler et al., 
2012). Indeed, many clinical practice guidelines recommend that non-
pharmacological interventions to be the first-line choice for managing BPSD. A 
number of non-pharmacological interventions have been successful at relieving 
BPSD, for example, music therapy, light therapy, and aromatherapy (Ayalon, Gum, 
Feliciano, & Arean, 2006; Azermai et al., 2012; Brodaty & Arasaratnam, 2012; 
Lawlor, 2002; Skjerve, Bjorvatn, & Holsten, 2004).  
Caregivers play a major role in taking care of dementia patients. Caring for these 
patients is similar to looking after children. However, the work of taking care of 
children decreases as the children grow older. In contrast, care for dementia patients 
 3 
 
never ceases, and it becomes more difficult to care for them over time because of the 
disease’s progression. Consequently, some caregivers become stressed and depressed 
from taking care of advanced-stage dementia patients. Thus, healthcare professionals 
also need to provide medical care for caregivers (C. Jones, Edwards, & Hounsome, 
2012). Numerous studies have shown that caregiver support programmes that helped 
patients to improve their conditions in many aspects also relieved caregivers’ 
burdens (Chien & Lee, 2008; Dias et al., 2008; Gitlin, Corcoran, Winter, Boyce, & 
Hauck, 2001; Haupt, Karger, & Janner, 2000; C. Jones et al., 2012; Lavoie et al., 
2005). For instance, Chien and Lee (2008) have conducted a single-blind, 
randomised control trial and have found that a single intervention, a disease-
management programme that educated family caregivers (12 sessions every other 
week, 2 hours per session) helped not only to improve both BPSD and 
institutionalisation but also to relieve caregiver burden and to improve caregivers’ 
quality of life. Similarly, numerous programmes have been developed to support 
both patients and caregivers (Chien & Lee, 2011; Gitlin, Winter, Dennis, Hodgson, 
& Hauck, 2010; Graff et al., 2007; Smits et al., 2007). For example, a disease 
management programme for family members in Hong Kong helped to improve 
patients’ institutionalisation experiences and caregivers’ quality of life (Chien & Lee, 
2011). Another programme was a bio-behavioural home-based intervention that also 
improved patients’ and caregivers’ quality of life (Gitlin et al., 2010). 
Community-based service is defined comprehensively by McLeroy, Norton, Kegler, 
Burdine, and Sumaya (2003) based on 4 aspects: 1) the community as “setting,” that 
is, services are offered through nearby community organisations such as schools, 
primary care clinics, etc.; 2) the community as “target,” in which services target most 
of the community; 3) the community as “resource,” when services take advantage of 
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community resources, including human resources, to provide interventions; and 4) 
the community as “agent,” when services are offered through community 
organisations or social groups. Regarding dementia, the community-based services in 
the previous studies could reflect the community as “setting,” for example, day care, 
respite care. In addition, the services are provided via “agent”, for example, in-home 
care, home care visits, social support groups, health promotion and teaching 
programmes, palliative care, rehabilitation, family caregiver support programmes, 
and psycho-educational nursing interventions. Some studies have shown that 
community-based interventions are effective and save costs compared with 
institutional care (Gaugler, Zarit, Townsend, Stephens, & Greene, 2003). Another 
study showed that earlier community-based service use in dementia postponed 
institutionalisation (Cantillon & de Grave, 2012). However, in some areas, caregivers 
remained dissatisfied with the availability and acceptability of some community-
based services (Forbes et al., 2008). This finding indicates that not every community-
based service provides effective care to everyone in a given area. Thus, each area, 
particularly rural areas, requires services that are individualised for dementia patients 
in their individual contexts. An appropriate tool for developing the community-based 
model in each community is needed. 
One of the tools that is helpful for developing the model using stakeholder 
participation is concept mapping, which is a method used for creating and organising 
ideas that was originally created in Novak’s research programme at Cornell 
University and used as an educational tool (J. D. Novak & Canas, 2007). Novak’s 
concept-mapping process is a group activity (J. D. Novak, 1990). The participants 
are asked first to generate ideas and then to organise them on a chart. The ideas are 
organised from top to bottom, with the most general ideas located at the top. 
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Relationships between ideas are highlighted by linking each idea with a labelled 
arrow. Although Novak’s mapping is most successfully applied to education, it has 
recently been used to promote healthcare provider learning and problem-solving in 
residential dementia care in Australia (S. M. Aberdeen, Leggat, & Barraclough, 
2010).  
Concept mapping was further developed by Trochim (W.  Trochim & Kane, 2005) to 
become more systematic and objective through the use of systematic processes and 
statistical techniques to generate statements and produce concept maps for specific 
purposes. Subsequently, Trochim’s concept mapping was applied to numerous 
aspects of healthcare (W.  Trochim & Kane, 2005). For example, concept mapping 
was used to identify research agendas, the causes of problems, solutions, and 
strategies (Dawson, Cargo, Stewart, Chong, & Daniel, 2013; Lobb, Pinto, & Lofters, 
2013; Neuman, Shahor, Shina, Sarid, & Saar, 2013; Reis et al., 2012; Stillman, 
Schmitt, & Rosas, 2012; Vaughn, Jacquez, & McLinden, 2012; Walker, Block, & 
Kawachi, 2012; Windsor & Murugan, 2012). Furthermore, concept mapping has 
been utilised to develop a logic model for healthcare, tools, and questionnaires (Chiu, 
2012; Jordan et al., 2013; Orsi, 2011; Yampolskaya, Nesman, Hernandez, & Koch, 
2004). Finally, it has been used to evaluate particular healthcare programmes (Chiu, 
2012).  
The principle of concept mapping is to extract stakeholders’ tacit knowledge and to 
organise their ideas in the form of a picture or a diagram. We can also now 
incorporate the findings from the new literature into participants’ ideas (van den 
Dungen, Hoeymans, Schellevis, & van Oers, 2013). One crucial feature of Novak’s 
principle is that it generates large-format concept maps, which often encompass all 
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pieces of the work. Nevertheless, Novak’s mapping is only a group process; there are 
no statistics or data analysis, and the concept mapping appears to be subjective. In 
contrast, Trochim’s concept mapping uses both a systematic approach and statistical 
analysis to build the concept maps. Therefore, it is more objective than Novak’s 
mapping. Nonetheless, Trochim’s mapping can focus on only one aspect because it 
leads with a focus question. For that reason, integrating the two types of concept 
mapping will help adjust the disadvantages and advantages of each method to 
develop a perfect method for structuring a concept map. The strength of both 
concept-mapping processes is stakeholder participation, which gives the participant a 
sense of ownership, resulting in more cooperation when we apply the obtained map 
to a real situation. In addition, BPSD are difficult to be managed by caregivers in 
particular situation such as in rural areas, in less educated populations, with a lack of 
facilities that support patient care (such as specialists’ availability, nursing homes, 
and anti-dementia agents). Thus, concept mapping can be used to determine the 
appropriate methods to assist patients and caregivers to cope with the difficulties of 
BPSD management. 
1.2 Statement of the Problem 
In Thailand, the prevalence of dementia was found to be high at approximately 
11.4%, compared with 5-7% reported globally (Prince et al., 2013; "Thailand 
Prevalence of Dementia in 2000," 2004). In addition, in one population-based study 
conducted in Bangkok, Thailand, 420 elderly people were screened for dementia. 
The study showed that 23 had dementia and 22 were undiagnosed (95.6%) 
(Jitapunkul, Chansirikanjana, & Thamarpirat, 2009). Furthermore, there are no 
official nursing homes in Thailand (Sasat, Choowattanapakorn, Pukdeeprom, Lertrat, 
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& Aroonsang, 2011). The general belief and culture requires that “parents look after 
their children from the time they are very young, and children should be grateful and 
repay them by taking care of them when they get older.” For reasons of conscience, 
family caregivers do not place their parents in nursing homes. However, as a result, 
Thai family caregivers always shoulder heavy burdens when caring for dementia 
patients. The results of one survey study in Thailand found that BPSD was the most 
disturbing to family caregivers (Muangpaisan et al., 2010). Consequently, the family 
caregivers required assistance in managing BPSD, including managing their stress 
and depression from taking care of their patients. 
In Thailand’s rural areas, most residents are poor. Therefore, most people are 
supported by government health insurance via a universal coverage health insurance 
policy (Health Insurance System Research Office, 2012). Healthcare services in 
government hospitals are provided free of charge. However, physicians have only 
limited authority to prescribe medications; they can only prescribe medications that 
are on the national list of essential medicines. Unfortunately, the list does not cover 
anti-dementia agents, for example, donepezil, galantamine, and rivastigmine. For 
these reasons, dementia progresses more rapidly in patients in the countryside than it 
does in those who receive anti-dementia agents. In addition, drug-related problems 
(DRPs) are commonly found among the elderly in rural areas. For example, 
Chongwiriyanurak (1999) conducted an interventional study in the elderly (n = 54) in 
one district of Thailand and identified 85 DRPs in 40 patients. The majority of DRPs 
identified involved failure to receive medication. Moreover, some family members 
have no time to take care of their relatives because they must work during the day (S. 
Namtatsanee, personal communication, April 11, 2013), and some patients thus need 
help from the community. Therefore, a community-based model with the active 
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participation of community members and various stakeholders is the best method for 
caring for people with dementia in rural areas. 
1.3 Objectives of the Study 
1.3.1 The General Objective 
The general aim of this study was to develop a community-based model involving 
the community, hospital, and family for managing dementia patients with BPSD. 
1.3.2 The Specific Objectives 
(a) To explore the problems in managing dementia patients with BPSD that confront 
family caregivers, healthcare providers, and communities. 
(b) To design a comprehensive model for managing dementia patients with BPSD 
using integrated concept mapping. 
(c) To evaluate the feasibility of the comprehensive model application in real 
practice. 
(d) To modify the developed model based on the stakeholders’ feedback using 
Novak’s concept mapping. 
1.4 Significance 
The benefits of a community-based model developed by concept mapping are as 
follows. The concept mapping process results in effective collaboration among 
community stakeholders. Because community residents participate in solving 
problems together, community empowerment is fostered, and the community 
becomes sustainably developed. In addition, this co-operative work forms the 
foundation for further developing other services or interventions through community 
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participation. Next, a community-based model created by stakeholders will help 
improve family caregivers’ quality of life and diminish their burdens, including their 
own suffering from caring for dementia patients. Eventually this community-based 
model will be used to guide additional model development in the community. 
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CHAPTER 2 
LITERATURE REVIEW 
Behavioural and psychological symptoms of dementia (BPSD) are common among 
dementia patients and are one of the causes of family caregiver burden in dementia 
care (Fauth & Gibbons, 2014; Taemeeyapradit, Udomittipong, & Tepparak, 2014). 
The impact of BPSD on caregiver burden, methods of BPSD assessment, standard 
guidance for BPSD management, and challenges of BPSD management are reviewed 
in this chapter. Then, community-based services for dementia patients are described. 
Finally, concept mapping, the method that was used in the current study, is reviewed 
in terms of its theoretical background and principles, procedures, and application in 
health research, including dementia research. 
2.1 Impact of BPSD on Caregiver Burden 
There are two types of caregivers: informal caregivers and formal caregivers (Family 
Caregiver Alliance, 2014). Formal caregivers are defined as a provider associated 
with a formal service system, whether a paid worker or a volunteer. Informal 
caregivers are family members or neighbours who have a personal relationship with 
the patients. 
 BPSD are one of the causes of caregiver burden, especially among family caregivers 
in countries that offer little professional caregiver support, such as China and 
Thailand (Rakkhamnuan & Lueboonthavatchai, 2012; Wang, Xiao, He, Ullah, & De 
Bellis, 2014). Caregiver burden is classified into 5 types based on the Caregiver 
Burden Inventory (CBI): physical, emotional, time-dependence, developmental, and 
social burdens (M. Novak & Guest, 1989). Physical burden consists of caregivers’ 
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feelings of chronic fatigue and damage to physical health (such as exhaustion). 
Emotional burden consists of the caregivers’ negative feelings toward their patients 
such as a sense of embarrassment. Time-dependence burden is the burden due to 
restrictions on the caregiver’s time, such as having to watch the patients constantly. 
Developmental burden consists of the caregivers’ feelings of being “off-time” in 
their development with respect to their peers, such as believing that they are “missing 
out” on life. Social burden consists of caregivers’ feelings of role conflict, such as 
marital problems. 
In China, Wang et al. (2014) administered a questionnaire survey on determinants of 
caregiver burden to 152 family caregivers of dementia patients. CBI and the 
Neuropsychiatric Inventory Questionnaire (NPI-Q) were used to measure caregiver 
burden and BPSD, respectively. The authors found that BPSD significantly increased 
family caregivers’ burden in terms of physical (p < 0.001), emotional (p < 0.01), 
time-dependent (p < 0.05), and developmental burden (p < 0.01).  
Correspondingly, a survey study was conducted with 90 family caregivers in 
Bangkok, Thailand (Rakkhamnuan & Lueboonthavatchai, 2012). The Zarit Burden 
Interview (ZBI) and the Behavioural Pathology in Alzheimer’s Disease Rating Scale 
(BEHAVE-AD) were used to assess caregiver burden and BPSD, respectively. These 
results also found that BPSD significantly increased caregiver burden (p < 0.01). 
The various BPSD have different levels of impact on caregiver burden. Five studies 
from countries such as Singapore, Japan, Taiwan, and the USA explained the effects 
of individual BPSD on caregiver burden and distress as follows. 
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Tan, Wong, and Allen (2005) conducted a non-randomised controlled study that 
aimed to assess the effects of BPSD on distress in a sample of formal (n = 27) and 
informal caregivers (n = 58) of dementia patients (n = 85) in Singapore. The 
Neuropsychiatric Inventory Nursing Home version (NPI-NH) and the 
Neuropsychiatric Inventory Caregiver Distress Scale (NPI-D) were used to assess 
BPSD and caregiver distress, respectively. Overall, informal caregivers reported 
significantly more distress than did formal caregivers (p = 0.001). In detail, delusions 
(p = 0.025), agitation/aggression (p = 0.012), depression/dysphoria (p = 0.002), and 
aberrant motor behaviour (p = 0.009) had greater significant effects on informal 
caregivers’ distress than formal caregivers’ distress. 
Matsumoto et al. (2007) performed a retrospective correlational study to determine 
the type of BPSD related to the burden and distress of 67 family caregivers who were 
caring for dementia patients in a Japanese community setting. The ZBI, the 
Neuropsychiatric Inventory (NPI), and the NPI-D were used to assess caregiver 
burden, BPSD, and caregiver distress, respectively. Caregiver distress, as measured 
with the NPI-D, was categorised into the following 3 levels: high (NPI-D score 4–5), 
moderate (NPI-D score 2–3), and low (NPI-D score 0–1) (Kaufer et al., 1998). The 
results showed that caregiver distress was significantly associated with caregiver 
burden (r = 0.51, p < 0.01). Moreover, in terms of individual symptoms, 
agitation/aggression was associated with the highest caregiver distress score (2.3 ± 
1.4). In addition to agitation/aggression, other symptoms such as delusions (2.1 ± 
1.6), hallucinations (1.4 ± 1.1), disinhibition (2.1 ± 1.2), irritability/lability (2.1 ± 
1.4), and aberrant motor behaviours (1.9 ± 1.1) were associated with high or 
moderate distress scores for half of the caregivers. By contrast, other symptoms, i.e., 
dysphoria/depression (0.7 ± 0.6), anxiety (1.4 ± 1.1), and euphoria/elation (0.0 ± 
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0.0), were associated with generally lower distress scores. Finally, 
apathy/indifference (1.4 ± 1.2) was associated with a low distress score for half of 
the caregivers.  
A correlational study was conducted to examine BPSD associated with caregiver 
burden in Taiwan (Huang, Lee, Liao, Wang, & Lai, 2012); symptoms were assessed 
using the NPI and the NPI-D, respectively. Overall, BPSD were significantly 
correlated with caregiver burden (r = 0.898, p < 0.001). Individually, delusions (r = 
0.469, p < 0.01), agitation/aggression (r = 0.431, p < 0.05), anxiety (r = 0.633, p < 
0.01), irritability/lability (r = 0.447, p < 0.01), depression/dysphoria (r = 0.322, p < 
0.05), disinhibition (r = 0.415, p < 0.05), sleep (r = 0.507, p < 0.01), 
apathy/indifference (r = 0.479, p < 0.01), and aberrant motor behaviour (r = 0.519, p 
< 0.01) were significantly associated with caregiver burden. In terms of the level of 
caregiver burden due to BPSD, as represented by the average with standard deviation 
(SD) of the NPI-D score, delusions were associated with the highest level of 
caregiver distress (3.2 ± 1.9), followed by aggression/agitation (2.6 ± 1.7), anxiety 
(2.6 ± 1.7), irritability/lability (2.6 ± 1.8), and depression/dysphoria (2.6 ± 1.8). By 
contrast, euphoria/elation was associated with the lowest level of caregiver distress 
(1.0 ± 2.2), followed by aberrant motor behaviour (1.8 ± 1.9), apathy/indifference 
(2.0 ± 1.7), eating changes (2.0 ± 1.8) and sleep disorders (2.3 ± 2.1). 
Khoo, Chen, Ang, and Yap (2013) conducted an observational study to examine the 
impact of BPSD on caregiver burden and patients’ quality of life among 667 dyads 
of dementia patients and their caregivers in Singapore. The NPI was used to assess 
BPSD and caregiver burden. The Quality of Life-Alzheimer’s Disease Scale (QOL-
AD) was used to evaluate patients’ quality of life. The results showed that BPSD 
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were associated with caregiver burden (p
2
 = 0.732, p < 0.0001) and patients’ quality 
of life (p
2
 = 0.066, p < 0.0001). The three BPSD that had the greatest impact on 
caregiver distress were agitation/aggression (p
2
 = 0.363, p < 0.001), 
depression/dysphoria (p
2
 = 0.353, p < 0.001), and irritability/lability (p
2
 = 0.331, p 
< 0.001), followed by anxiety (p
2
 = 0.328, p < 0.0001) and disinhibition (p
2
 = 
0.312, p < 0.0001). In terms of patients’ quality of life, the BPSD that had the 
greatest impact were depression/dysphoria (p
2
 = 0.058) and apathy/indifference (p
2
 
= 0.042, p < 0.0001). By contrast, the BPSD with the least impact on patients’ 
quality of life was hallucinations (p
2
 = 0.016, p < 0.005). Moreover, 
elation/euphoria (p
2
 = p > 0.05) and aberrant motor behaviour (p
2
 = 0.005, p > 
0.05) had no impact on patients’ quality of life. 
Fauth and Gibbons (2014) conducted a retrospective correlational study to identify 
the BPSD that affected caregiver burden and depression symptoms among 177 
caregivers in the USA. BPSD and caregiver distress were assessed using the NPI and 
the Revised Memory and Behaviour Problem Checklist (RMBPC), respectively, and 
caregiver depressive symptoms were assessed with the Geriatric Depressive Scale 
(GDS). Overall, caregiver burden, assessed according to the RMBPC’s frequency (r 
= 0.245, p < 0.001) and distress subscales (r = 0.402, p < 0.001), was significantly 
correlated with caregiver depressive symptoms. The three BPSD that most affected 
caregiver distress (as mentioned, BPSD were measured according to NPI score) were 
delusions (2.63 ± 1.15), agitation/aggression (2.63 ± 1.20), and irritability/lability 
(2.56 ± 1.04), followed by anxiety (2.35 ± 0.97), apathy/indifference (2.35 ± 1.09), 
disinhibition (2.27 ± 1.33), depression/dysphoria (2.26 ± 1.08), sleep (2.16 ± 1.28), 
and aberrant motor behaviour (2.03 ± 1.02). By contrast, the least distressing 
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symptoms were elation (1.45 ± 1.26), eating changes (1.81 ± 1.17), and 
hallucinations (1.86 ± 1.27). In addition, the BPSD that significantly impacted 
caregiver depressive symptoms were delusions ( = 0.177, p = 0.022), 
agitation/aggression ( = 0.248, p = 0.001), depression/dysphoria ( = 0.185, p = 
0.017), anxiety ( = 0.342, p = 0.000), apathy/indifference ( = 0.201, p = 0.01), 
disinhibition ( = 0.210, p = 0.007), irritability/lability ( = 0.276, p = 0.000), and 
aberrant motor behaviour ( = 0.166, p = 0.032). 
In conclusion (Table 2.1), the three individual BPSD that most affected caregiver 
burden/distress, at either moderate or high levels, were agitation/aggression, 
irritability/lability, and disinhibition; all of the studies found these results. By 
contrast, all of the studies found that euphoria/elation had a low impact on caregiver 
distress. 
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Table 2.1  
Study Findings for Behavioural and Psychological Symptoms of Dementia (BPSD) that Affected Caregiver Burden/Distress 
Author(s) Country Formal/ 
Informal 
Caregivers 
BPSD Related to High or Moderate 
Distress/Burden*  
BPSD Related to Low Distress/Burden* 
Tan et al. 
(2005) 
Singapore Formal 
caregivers 
(n = 27) 
Agitation/aggression, irritability/lability, disinhibition, 
anxiety, hallucination, indifference/apathy, eating 
changes, sleep disorders, aberrant motor behaviours, and 
delusion 
Depression/dysphoria and euphoria/elation 
Informal 
caregivers 
(n = 58) 
Agitation/aggression, delusion, disinhibition, aberrant 
motor behaviours, anxiety, sleep disorders, indifference, 
hallucination, depression/dysphoria, and eating changes 
Euphoria/elation 
Matsumoto 
et al. 
(2007) 
Japan Informal 
caregivers  
(n = 67) 
Agitation/aggression, delusion, irritability/lability, and 
disinhibition 
Aberrant motor behaviours, indifference, 
anxiety, hallucination, depression/dysphoria, 
and euphoria/elation 
Huang et 
al. (2012) 
Taiwan Informal 
caregivers  
(n = 88) 
Delusion, agitation/aggression, anxiety, 
irritability/lability, depression/dysphoria, hallucination, 
disinhibition, sleep disorders, eating changes, and 
indifference/apathy 
Aberrant motor behaviours and 
euphoria/elation 
Khoo et al. 
(2013) 
Singapore Informal 
caregiver 
(n = 667) 
Agitation/aggression, depression/dysphoria, 
irritability/lability, anxiety, and disinhibition 
Euphoria/elation, indifference/apathy, and 
eating changes 
Fauth and 
Gibbons 
(2014) 
USA Informal 
caregivers 
(n = 177) 
Delusion, agitation/aggression, irritability/lability, 
anxiety, indifference/apathy, disinhibition, 
depression/dysphoria, sleep disorders, and aberrant 
motor behaviours 
Hallucination, eating changes, and 
euphoria/elation 
*The distress/burden levels were classified based on the Neuropsychiatric Inventory Caregiver Distress Scale (NPI-D) and the Revised Memory and 
Behaviour Problem Checklist (RMBPC): low distress = 0–1; moderate and high distress = 2–5. These criteria do not include Khoo et al.’s (2013) classification 
of the distress/burden level based on the value of 2. 
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2.2 Methods of Assessing BPSD 
Numerous assessment scales for BPSD have been developed and used, including the 
Apathy Inventory (Clinician Version), the Behavioural Pathology in Alzheimer’s 
Disease Rating Scale (BEHAVE-AD), the Columbia University Scale for 
Psychopathology in Alzheimer’s Disease (CUSPAD), the Consortium to Establish a 
Registry for Alzheimer’s Disease Behaviour Rating Scale for Dementia (CERAD-
BRSD), and the NPI (Tampi et al., 2011). The NPI and the BEHAVE-AD have been 
widely used to assess BPSD in a number of countries, including Thailand (Baranzini 
et al., 2013; Boada, Tarraga, Modinos, Diego, & Reisberg, 2006; Ferreira, Martins, 
Ribeiro, & Fernandes, 2015; Kudo, 2011; Rakkhamnuan & Lueboonthavatchai, 
2012; Sclan et al., 1996; Senanarong et al., 2005; Thavichachart et al., 2006). 
Reisberg and colleagues developed the BEHAVE-AD in 1987 (Reisberg, Auer, & 
Monteiro, 1997). This scale has a greater focus on BPSD than did the previous scale, 
which also included cognitive impairment. The scale consists of 7 symptoms, 
including paranoid and delusional ideation, hallucinations, activity disturbances, 
aggressiveness, diurnal rhythm disturbances, affective disturbance, and anxieties and 
phobias. The last part of this scale includes a “global” rating as an overall rating for 
all symptoms of caregivers’ distress. The BEHAVE-AD was the first version that 
was used to evaluate patients through caregiver interviews. Later, in 1996, Auer, 
Monteiro, and Reisberg (1996) developed the Empirical Behavioural Pathology in 
Alzheimer's Disease (E-BEHAVE-AD) Rating Scale. This version was developed for 
clinicians to evaluate patients through observation. 
The Neuropsychiatric Inventory is also used for BPSD assessment, and it was 
developed into three versions. The first version, which was developed by Cummings 
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et al. (1994), has 10 symptom items, as follows: delusions, hallucinations, 
dysphoria/depression, anxiety, agitation/aggression, euphoria/elation, disinhibition, 
irritability/lability, apathy/indifference, and aberrant motor activity. Later, they 
added the following two symptoms to cover all common BPSD: night time behaviour 
disturbances and appetite and eating abnormalities (Cummings, 1997). This 
instrument was developed into the following three versions: a brief questionnaire 
(NPI-Q), a nursing home version (NPI-NH), and a self-administered caregiver 
version (CGA-NPI). The NPI-Q was developed for routine clinical practice (Kaufer 
et al., 2000). The NPI-NH is the version that is used by professional caregivers in 
long-term care settings (Wood et al., 2000). Finally, the CGA-NPI is a form that 
caregivers use to evaluate patients (Kang et al., 2004). 
J. Cohen-Mansfield and Golander (2011) showed that the BEHAVE-AD and the NPI 
are equivalent in terms of BPSD assessment. In a sample of 74 dementia patients 
from 9 nursing homes in Israel, they compared the following 4 BPSD assessment 
tools: the BEHAVE-AD, NPI-NH, CERAD-BRSD, and CUSPAD. The results 
showed that the NPI-NH and the BEHAVE-AD provided similar BPSD assessments.  
In addition to their similarity, the BEHAVE-AD and the NPI are effective tools and 
are widely used in both research and clinical practice (Ferreira et al., 2015; Reisberg 
et al., 2014; Sclan et al., 1996; Selbaek & Engedal, 2012). Therefore, these two 
questionnaires were also used to assess BPSD in the current study. 
2.3 Standard Guidance for BPSD Management 
Managing BPSD entails both pharmacological and non-pharmacological 
interventions. In the past, pharmacological intervention was the first line of therapy 
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for BPSD. Subsequently, numerous studies showed harmful effects of antipsychotics 
on dementia patients, such as acute myocardial infarction, extrapyramidal syndrome, 
sedation, and cerebrovascular accidents (Atti et al., 2014; Gareri, De Fazio, 
Manfredi, & De Sarro, 2014; Lin et al., 2014; Ma et al., 2014; Schmedt & Garbe, 
2013). Moreover, several studies found that antipsychotics were related to increased 
mortality in dementia patients (Lopez et al., 2013; Murray-Thomas et al., 2013; 
Musicco et al., 2011; Piersanti et al., 2014). Therefore, recent standard guidelines 
recommend non-pharmacological intervention as the first line of treatment for BPSD 
(Alzheimer's Society, 2011; American Psychiatric Association, 2010; British 
Columbia's Residentia Care Facilities, 2012; Herrmann, 2001; Hersch & Falzgraf, 
2007; National Collaborating Centre for Mental Health, 2007; National Resource 
Center for Academic Detailing, 2013; Scottish Intercollegiated Guidelines Network, 
2006; The Neurological Society of Thailand, 2008; The NSW Ministry  of Health 
and the Royal Australian and New Zealand College of Psychiatrists, 2013). 
Azermai et al. (2012) identified several standard guidelines (published between 
January 2003 and November 2010) through Medline and a hand search of the web 
sites of medical societies and guideline organisations and systematically appraised 
them based on the AGREE (Appraisal of Guidelines, REsearch and Evaluation) 
collaboration (The AGREE Collaboration, 2003). The high-quality BPSD 
management guidelines of the following five institutions were included in the 
appraisal: the Dutch College of Clinical Geriatrics (DCGP; 2005) (Dutch College of 
Clinical Geriatrics, 2005), the National Institute for Health and Clinical Excellence 
(NICE; 2006) (National Institute for Health and Clinical Excellence, 2006), the 
Scottish Intercollegiate Guideline Network (SIGN; 2006) (Scottish Intercollegiated 
Guidelines Network, 2006), the Third Canadian Consensus Conference (CCC, 3rd; 
  
20 
 
2007) (Canadian Consensus Conference (3rd), 2007), and the Ministry of Health 
Malaysia (MOH (M); 2009) (Ministry of Health Malaysia, Malaysian Psychiatric 
Association, Academy of Medicine Malaysia, & Malaysian Society of 
Neurosciences, 2009). 
2.3.1 Non-Pharmacological Management 
According to Azermai et al.’s (2012) study, most guidelines recommended initial 
non-pharmacological BPSD management. If non-pharmacological intervention fails, 
the guidelines recommend the start of medication. The non-pharmacological 
interventions that the guidelines of the 5 institutions (CCC, DCGP, MOH (M), 
NICE, and SIGN) recommend including aromatherapy, multisensory stimulation, 
music therapy, massage and touch interventions, bright light therapy, and behaviour 
management (Table 2.2). Only 2 interventions are recommended with strong 
evidence from most guidelines, as follows: music therapy and behaviour 
management. 
In the dementia guidelines from Thailand (The Neurological Society of Thailand, 
2008), non-pharmacological intervention is also recommended as a first-line 
treatment for BPSD. The interventions are applied to manage different symptoms; 
for example, behaviour management, psychotherapy, exercise, music therapy, 
massage, aromatherapy, and environment arrangement are recommended to manage 
agitation/aggression. However, in contrast to the five standard guidelines reviewed 
by Azermai et al. (2012), these interventions do not show supported evidence. 
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2.3.2 Pharmacological Management 
Pharmacological intervention is initiated after non-pharmacological treatment has 
failed. According to the findings of Azermai et al. (2012), antipsychotics, 
antidepressants, and benzodiazepine are supported by most high-quality standard 
guidelines (Table 2.2). Table 2.2 shows that in terms of antipsychotics, the 
indications are psychosis, agitation, and aggression. Regarding the types of 
antipsychotics, haloperidol, a conventional antipsychotic, and risperidone and 
olanzapine, atypical antipsychotics, are recommended for BPSD management. 
Moreover, the choice of antipsychotics is based on individual factors and analyses of 
the risks and benefits. For any antipsychotic, an initial low dose with upward titration 
is recommended. Furthermore, clinical outcomes should be assessed every 3 months 
or based on clinical need. If the patient’s symptoms are stable, discontinuation of the 
medication should be considered. Another psychotropic medication, benzodiazepine, 
is recommended for short-term use to reduce acute agitation or agitation based on 
anxiety. Finally, selective serotonin reuptake inhibitors are antidepressants that are 
recommended for managing depression. Acetylcholinesterase and memantine are not 
recommended for BPSD management. All recommendations are illustrated in Figure 
2.1. 
In terms of the Thai guidelines for dementia (The Neurological Society of Thailand, 
2008), various types of psychotropic drugs are recommended, and evidence supports 
these recommendations. Overall, the recommendations are similar to those in the 
review by Azermai et al. (2012); for example, there is strong evidence to support the 
recommendation of haloperidol and risperidone for managing psychosis, but the 
evidence to support the recommendation of olanzapine is weaker. In addition, 
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benzodiazepine is suggested for managing agitation and anxiety. Moreover, 
antidepressants, especially selective serotonin reuptake inhibitors, are suggested for 
the treatment of depression; this treatment is strongly supported by evidence. Finally, 
mood stabilisers such as valproate and carbamazepine are recommended for 
managing aggression/agitation and sexual disinhibition. 
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Table 2.2 
Non-Pharmacological and Pharmacological BPSD Management Based on Recommendations Extracted from the Systematic Appraisal of 
Dementia Guidelines by Azermai et al. (2012)  
Recommendations
a 
Sufficient 
agreement? 
Non-pharmacological interventions 
   Aromatherapy 
   Multisensory stimulation 
   Music 
   Massage and touch interventions 
   Bright light therapy 
   Behaviour management 
 
No 
No 
Yes 
No 
No 
Yes 
Pharmacological interventions 
   After trial with non-pharmacological interventions, in combination with non-pharmacological interventions or 
when non-pharmacological interventions have failed 
 
Yes 
Antipsychotics 
   For (severe) psychosis and/or aggression/agitation 
   Atypical antipsychotics (risperidone, olanzapine) 
   Conventional antipsychotics (haloperidol) 
   Choice based on individual risk/benefit analysis 
   Start at low dose and titrate upwards 
   Time-limited use and regular reassessment (every 3 months or according to clinical need) 
   Discontinue after behavioural stability 
 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Benzodiazepines 
   For acute agitation or agitation based on anxiety (short-term use) 
 
Yes 
Antidepressants 
   For comorbid depression, selective serotonin reuptake inhibitors 
 
Yes 
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Table 2.2 continued. 
Recommendations
a 
Sufficient 
agreement? 
Acetylcholinesterase inhibitors (A-ChI) 
   Use of A-ChI    
 
No 
Memantine 
   Use of memantine 
 
No 
a
 Bold statements: recommendations that were supported with strong evidence by most guidelines.  
Source: Adapted from “Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms” by Azermai et al. 
(2012) 
